Endocrinol Metab.  2016 Mar;31(1):64-71. 10.3803/EnM.2016.31.1.64.

Serum γ-Glutamyl Transferase Is Inversely Associated with Bone Mineral Density Independently of Alcohol Consumption

• Choi HS
• Kim KJ
• Rhee Y
• Lim SK

• KMID: 2169694
• DOI: http://doi.org/10.3803/EnM.2016.31.1.64

Abstract

BACKGROUND
γ-Glutamyl transferase (GGT) is a well-known marker of chronic alcohol consumption or hepatobiliary diseases. A number of studies have demonstrated that serum levels of GGT are independently associated with cardiovascular and metabolic disorders. The purpose of this study was to test if serum GGT levels are associated with bone mineral density (BMD) in Korean adults.
METHODS
A total of 462 subjects (289 men and 173 women), who visited Severance Hospital for medical checkup, were included in this study. BMD was measured using dual energy X-ray absorptiometry. Cross-sectional association between serum GGT and BMD was evaluated.
RESULTS
As serum GGT levels increased from the lowest tertile (tertile 1) to the highest tertile (tertile 3), BMD decreased after adjusting for confounders such as age, body mass index, amount of alcohol consumed, smoking, regular exercise, postmenopausal state (in women), hypertension, diabetes mellitus, and hypercholesterolemia. A multiple linear regression analysis showed a negative association between log-transformed serum GGT levels and BMD. In a multiple logistic regression analysis, tertile 3 of serum GGT level was associated with an increased risk for low bone mass compared to tertile 1 (odds ratio, 2.271; 95% confidence interval, 1.340 to 3.850; P=0.002).
CONCLUSION
Serum GGT level was inversely associated with BMD in Korean adults. Further study is necessary to fully elucidate the mechanism of the inverse relationship.

Keyword

Gamma-glutamyltransferase; Metabolic disorders; Bone density

MeSH Terms

Absorptiometry, Photon
Adult
Alcohol Drinking*
Body Mass Index
Bone Density*
Diabetes Mellitus
gamma-Glutamyltransferase
Humans
Hypercholesterolemia
Hypertension
Linear Models
Logistic Models
Male
Smoke
Smoking
Transferases*
Smoke
Transferases
gamma-Glutamyltransferase

Reference

1. Zhang H, Forman HJ, Choi J. Gamma-glutamyl transpeptidase in glutathione biosynthesis. Methods Enzymol. 2005; 401:468–483. PMID: 16399403.

2. Taniguchi N, Ikeda Y. Gamma-glutamyl transpeptidase: catalytic mechanism and gene expression. Adv Enzymol Relat Areas Mol Biol. 1998; 72:239–278. PMID: 9559055.

3. Lee DH, Silventoinen K, Jacobs DR Jr, Jousilahti P, Tuomileto J. gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab. 2004; 89:5410–5414. PMID: 15531490.

4. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2003; 49:1358–1366. PMID: 12881453.

5. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women’s Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2007; 27:2729–2735. PMID: 17932318.

6. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007; 27:127–133. PMID: 17095717.

7. Meisinger C, Doring A, Schneider A, Lowel H. KORA Study Group. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis. 2006; 189:297–302. PMID: 16483579.

8. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation. 2005; 112:2130–2137. PMID: 16186419.

9. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, et al. Gamma-glutamyltransferase and diabetes: a 4 year follow-up study. Diabetologia. 2003; 46:359–364. PMID: 12687334.

10. Meisinger C, Lowel H, Heier M, Schneider A, Thorand B. KORA Study Group. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med. 2005; 258:527–535. PMID: 16313476.

11. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke. 2000; 31:1851–1855. PMID: 10926946.

12. Nakanishi N, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2004; 27:1427–1432. PMID: 15161799.

13. Andre P, Balkau B, Vol S, Charles MA, Eschwege E. DESIR Study Group. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care. 2007; 30:2355–2361. PMID: 17586745.

14. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol. 1995; 142:699–708. PMID: 7572939.

15. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004; 134:489–492. PMID: 14988435.

16. Zaidi M. Skeletal remodeling in health and disease. Nat Med. 2007; 13:791–801. PMID: 17618270.

17. Niida S, Kawahara M, Ishizuka Y, Ikeda Y, Kondo T, Hibi T, et al. Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor. J Biol Chem. 2004; 279:5752–5756. PMID: 14634009.

18. Hiramatsu K, Asaba Y, Takeshita S, Nimura Y, Tatsumi S, Katagiri N, et al. Overexpression of gamma-glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis. Endocrinology. 2007; 148:2708–2715. PMID: 17363454.

19. Levasseur R, Barrios R, Elefteriou F, Glass DA 2nd, Lieberman MW, Karsenty G. Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. Endocrinology. 2003; 144:2761–2764. PMID: 12810527.

20. Asaba Y, Hiramatsu K, Matsui Y, Harada A, Nimura Y, Katagiri N, et al. Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption. Bone. 2006; 39:1276–1282. PMID: 16942925.

21. Lieberman MW, Wiseman AL, Shi ZZ, Carter BZ, Barrios R, Ou CN, et al. Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci U S A. 1996; 93:7923–7926. PMID: 8755578.

22. Ristoff E, Larsson A. Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis. 2007; 2:16. PMID: 17397529.

23. Goodman SI, Mace JW, Pollack S. Serum gamma-glutamyl transpeptidase deficiency. Lancet. 1971; 1:234–235. PMID: 4099892.

24. Wright EC, Stern J, Ersser R, Patrick AD. Glutathionuria: gamma-glutamyl transpeptidase deficiency. J Inherit Metab Dis. 1980; 2:3–7. PMID: 6118466.

25. Hammond JW, Potter M, Wilcken B, Truscott R. Siblings with gamma-glutamyltransferase deficiency. J Inherit Metab Dis. 1995; 18:82–83. PMID: 7623451.

26. Iida M, Yasuhara T, Mochizuki H, Takakura H, Yanagisawa T, Kubo H. Two Japanese brothers with hereditary gamma-glutamyl transpeptidase deficiency. J Inherit Metab Dis. 2005; 28:49–55. PMID: 15702405.

27. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004; 38:535–539. PMID: 15346644.

28. Darley-Usmar VM, Severn A, O’Leary VJ, Rogers M. Treatment of macrophages with oxidized low-density lipoprotein increases their intracellular glutathione content. Biochem J. 1991; 278(Pt 2):429–434. PMID: 1898336.

29. Deneke SM, Baxter DF, Phelps DT, Fanburg BL. Increase in endothelial cell glutathione and precursor amino acid uptake by diethyl maleate and hyperoxia. Am J Physiol. 1989; 257(4 Pt 1):L265–L271. PMID: 2801955.

30. Takahashi Y, Oakes SM, Williams MC, Takahashi S, Miura T, Joyce-Brady M. Nitrogen dioxide exposure activates gamma-glutamyl transferase gene expression in rat lung. Toxicol Appl Pharmacol. 1997; 143:388–396. PMID: 9144455.

31. Kugelman A, Choy HA, Liu R, Shi MM, Gozal E, Forman HJ. Gamma-glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am J Respir Cell Mol Biol. 1994; 11:586–592. PMID: 7946387.

32. Markey CM, Rudolph DB, Labus JC, Hinton BT. Oxidative stress differentially regulates the expression of gamma-glutamyl transpeptidase mRNAs in the initial segment of the rat epididymis. J Androl. 1998; 19:92–99. PMID: 9537296.

33. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002; 82:47–95. PMID: 11773609.

34. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001; 17:189–212. PMID: 11424232.

35. Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun. 2001; 288:275–279. PMID: 11594785.

36. Grassi F, Tell G, Robbie-Ryan M, Gao Y, Terauchi M, Yang X, et al. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci U S A. 2007; 104:15087–15092. PMID: 17848519.

37. Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest. 1990; 85:632–639. PMID: 2312718.

38. Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med. 2001; 31:509–519. PMID: 11498284.

39. Collier J. Bone disorders in chronic liver disease. Hepatology. 2007; 46:1271–1278. PMID: 17886334.

40. Nilssen O, Forde OH, Brenn T. The Tromso Study. Distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol. 1990; 132:318–326. PMID: 1973595.